Clinical Data Integrity: Clean US FDA Inspection No Guarantee That DoJ Won’t Investigate

 
• By Sue Sutter
  
Escalator
Drug sponsors need to have clear processes in place for escalating concerns about clinical data fraud. • Source: Shutterstock

More from Clinical Trials

More from R&D